SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-024289
Filing Date
2022-02-16
Accepted
2022-02-16 16:32:25
Documents
14
Period of Report
2022-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226979d1_8k.htm   iXBRL 8-K 23937
2 EXHIBIT 99.1 tm226979d1_ex99-1.htm EX-99.1 24813
3 GRAPHIC tm226979d1_ex99-1img001.jpg GRAPHIC 11570
  Complete submission text file 0001104659-22-024289.txt   244129

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20220216.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20220216_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20220216_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm226979d1_8k_htm.xml XML 3611
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 22644008
SIC: 2834 Pharmaceutical Preparations